首页 | 本学科首页   官方微博 | 高级检索  
检索        

基质金属蛋白酶2基因多态性与缺血性收缩性心衰预后相关
引用本文:华倚虹,宋丽,吴娜琼,鲁向锋,谢高强,张健,孟宪敏,顾东风,杨跃进.基质金属蛋白酶2基因多态性与缺血性收缩性心衰预后相关[J].中国分子心脏病学杂志,2009,9(1):38-42.
作者姓名:华倚虹  宋丽  吴娜琼  鲁向锋  谢高强  张健  孟宪敏  顾东风  杨跃进
作者单位:1. 阜外心血管病医院心内科心力衰竭诊治中心,100037
2. 阜外心血管病医院中心实验室,100037
3. 阜外心血管病医院循证医学和群体遗传,100037
4. 阜外心血管病医院网络防治部,100037
基金项目:中央级公益性科研专项基金 
摘    要:目的基质金属蛋白酶家族(Matrix metalloproteinases,MMPs)是一组蛋白溶解酶系,在心肌细胞外基质降解过程中发挥重要作用。MMP-2作为家族中的重要成员,在心力衰竭心肌重构过程中起关键作用。我们推测MMP-2基因多态性可能会影响收缩性心衰的预后。方法对387位缺血性收缩性心衰患者进行随访,用限制性片段长度多态性的方法(restriction fragment length polymorphism,RFLP)分析MMP-2基因的三个单核苷酸多态性(single nucleotide polymorphisms,SNPs)位点rs243864,rs243866,rs17859821。结果随访到335位患者,随访率86.6%。在随访期间(0~47个月,中位随访时间24个月),有72例(21.5%)患者死亡,56例(16.7%)患者因心衰再次入院,3例(0.9%)患者再次心肌梗塞,24例(7.2%)再次血运重建。1年、2年、3年的生存率分别是86%、79%、73%。MMP-2 rs17859821 A等位基因携带者全因死亡率、心源性死亡率、心衰死亡率和主要心脏不良事件率(major adveme cardiac event,MACE)均高于GG基因型者(OR=0.513,0.416,0.472,0.671;P=0.010,0.002,0.021,0.022)。使用Cox回归分析校正年龄、束支传导阻滞、LVEF和NYHA分级后,A等位基因携带者心源性死亡率和心衰死亡率仍显著或临界显著低于GG基因型者(OR=0.475,0.518;P=0.010,0.050)。结论研究结果提示携带MMP-2 rs17859821A等位基因的缺血陛收缩性心衰患者预后较好。

关 键 词:MMP-2  多态性  收缩性心力衰竭  预后

Polymorphisms of MMP-2 Gene are Associated with the Prognosis of Systolic Heart Failure
HUA Yi-hong,SONG Li,WU Na-qiong,LU Xiang-feng,XIE Gao-qiang,ZHANG Jian,MENG Xian-min,GU Dong-feng,YANG Yue-jin.Polymorphisms of MMP-2 Gene are Associated with the Prognosis of Systolic Heart Failure[J].Molecular Cardiology of China,2009,9(1):38-42.
Authors:HUA Yi-hong  SONG Li  WU Na-qiong  LU Xiang-feng  XIE Gao-qiang  ZHANG Jian  MENG Xian-min  GU Dong-feng  YANG Yue-jin
Institution:HUA Yi- hong , SONG Li, WU Na-qiong, LU Xiang-feng, XIE Gao-qiang, ZHANG Jian, MENG Xian-min, GU Dong-feng , YANG Yue-jin
Abstract:Objective Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes responsible for myocardial extracellular protein degradation. MMP-2 is an important member of MMPs. MMP- 2 has been demonstrated to play a pivotal role in myocardial remodeling process that occurs in congestive heart failure (HF). We hypothesized MMP-2 genetic variations could influence the prognosis of systolic HF. Methods To test our hypothesis, we performed a follow-up study of 387 patients with systolic HF caused by myocardial infarction. Three single nueleotide polymorphisms (SNPs) of MMP-2 (rs243864, rs243866, rs17859821 ) were analyzed by restriction fragment length polymorphism (RFLP) methods. Results Three hundreds and thirty five patients (86. 6% ) were followed up. At follow up (0-47month, median 24 months), 72 patients (21.5%) died, 56 patients ( 16.7% ) were readmitted because of HF, 3 patients (0.9%) bad recurrent myocardial infarction, 24 patients (7. 2% ) had repeat revaseularization. One, two, and three year survival rates were 86% , 79% and 73%. All cause death rate, cardiac death rate, HF death rate and MACE rate were lower in MMP-2 rs17859821 A allele carriers than did GG genotype carriers ( OR = 0. 513,0. 416,0. 472, 0. 671 ;P =0. 010,0.002,0.021, 0. 022). After adjustment for age, bundle branch block, LVEF and NYHA grade by using cox regression analysis, cardiac death rate and HF death rate were still lower in MMP-2 A allele carriers than did GG genotype carriers( OR = 0. 475 and 0. 518 ;P = 0. 010,0. 050). Conclusion The findings of the present study suggest that MMP-2 rs17859821 A allele is associated with better prognosis of systolic heart failure in the northern Han Chinese population.
Keywords:MMP-2
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号